News About: Pharm. Industry
Green Cross Cell creates stepping stones to attract investments and enter the U.S. market with Maryland
Green Cross Cell(Deuk-Joo Lee), a cell therapy company, announced on the 6th that the company signed a ‘memorandum of understanding(MOU) for promotion of investments’ with the Maryland state of the U.S.
Under the MOU...
Samsung Biologics will manufacture biologics on behalf of a European pharma
Samsung Biologics will manufacture biologics on behalf of a foreign pharmaceutical company.
Samsung Biologics announced on the 6th that the foreign company was a pharmaceutical company headquartered in Europe and it ...
Teva-Handok acquires approval of ‘CINQAIR,’ biologic for treatment of severe asthma patients
Teva-Handok(CEO Sun-Dong Park) announced that ‘CINQAIR(generic name: reslizumab),’ a new monoclonal antibody injection for the treatment of asthma, acquired approval from the Ministry of Food and Drug Safety on the 4t...
Pharmas to enjoy 10 days of holiday this October
While the government designated the 2nd of October as a temporary holiday, pharmaceutical companies are expected to enjoy 10 days of holiday this October.
Yakup Shinmoon checked plans for the 2nd of October on major ...
Hanmi Pharm ranked the top in ratio of doctors having experience of prescribing the company’s product within a month
A survey on doctors showed Yuhan Corporation, the top sales pharmaceutical company last year, was ranked the top in positive sections, such as ethicality, R&D and reliability, and Hanmi Pharm was chosen a pharmaceutic...
Celgene Korea appoints Tae-Jin Ham as new CEO
Celgene Korea announced appointment of Tae-Jin Ham, a new CEO, from the 1st of September.
CEO Tae-Jin Ham joined in Celgene in 2015 and continued to hold multiple positions, such as a head of the Asia region strategy...
CKD & MSD Korea adopt VR marketing program for ‘Januvia’
Chong Kun Dang(CEO Young-Joo Kim, CKD) and MSD Korea(CEO Avi BenShoshan) announced on the 6th that they implemented ‘Januvia VR Detail,’ a virtual reality(VR) program, in the field of the antidiabetic ‘Januvia’ busine...
CJ HealthCare applies new drug approval of acid reflex treatment
The CJ HealthCare’s first new medicine, an acid reflux treatment, has taken a approval process in Korea its launch.
CJ HealthCare(CEO Seok-Hee Kang) announced on the 4th that it applied product approval of ‘tegopraza...
ISU Abxis, Celltrion Bukwang record highest R&D/sales ratio in order
While KOSPI listed pharmaceutical companies had narrowly enlarged R&D expenses in the 1st half of this year compared to the same period of the last year, KOSDAQ listed pharmaceutical companies stayed the same in the i...
Gilead-Yuhan’s co-promotion agreement for Sovaldi and Harvoni
Gilead Sciences Korea(CEO Seung-Woo Lee) and Yuhan Corporation(CEO Jung-Hee Lee) announced a co-promotion ceremony of ‘Sovaldi’ and ‘Harvoni,’ chronic hepatitis C treatments, on the 31st of August.
The co-promotion a...
